It turns out that the pause on shipments of Sarepta's Duchenne muscular dystrophy (DMD) gene therapy Elevidys over safety concerns has been short-lived. The FDA's request to suspend distribution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback